Anticoagulant monitoring
| Anticoagulant monitoring | See also Thrombolytic therapy . |
| Heparin (standard, unfractionated) | |
| Prior to commencing therapy | FBC , platelet count ; baseline APTT , INR if patient on warfarin; PT if warfarin treatment planned. |
| During therapy | Platelet counts 2-3 times weekly are recommended. |
| Continuous IV infusion | APTT ; check therapeutic interval with laboratory. In the first 24 hours, frequent assessment may be required, but the APTT should not be performed <4 hours after any change in dose. Subsequently, a daily APTT usually suffices. |
| Intermittent IV injection | Monitoring not of value. |
| Prophylactic SC
injection (low dose heparin) |
Monitoring not of value. |
| If bleeding occurs | APTT ; FBC , platelet count . Check other medications with patient and/or from records. Concomitant aspirin or other NSAID increase the risk of bleeding; their effect on platelet function is predictable and testing is not indicated. The possibility of a pre-existent acquired or inherited bleeding disorder should also be considered. |
| If progression of thrombosis,
or thrombosis in other site(s) |
|
| Inadequate anticoagulation | APTT . |
| Heparin-induced
thrombocytopenia (HIT type II) |
FBC , platelet count ; heparin-dependent platelet antibodies if significant thrombocytopenia is documented. |
| Antithrombin III deficiency | Antithrombin III assay: should be deferred until heparin has been ceased. See under Thrombosis - venous. |
| Low Molecular Weight Heparin (LMWH)
and heparinoids |
The standard dose protocol is based on body weight; monitoring is not usually required except in renal failure or other high risk bleeding situations. Heparin-induced thrombocytopenia is less common than with standard, unfractionated heparin, but may occur: see above. |
| Prophylactic SC injection | Monitoring is not cost-effective and is not indicated. |
| Continuous IV infusion (full
dose, therapeutic LMWH) |
Anti Xa assay is the appropriate test, if testing is required; for therapeutic interval, consult pathologist. |
| Oral anticoagulants | INR . |
| If bleeding occurs | |
| Excessive anticoagulation | INR . |
| Alcohol | |
| Diet | |
| Intercurrent illness | |
| Cardiac failure | |
| Diarrhoea | |
| Other
drugs esp |
Consult pathologist/pharmacist about drug interactions; consider possibility of recent change in dose, introduction of new, or non-prescribed, medications. |
| Analgesics | |
| Antibiotics | |
| Aspirin, other NSAID | Predictable effect on platelet function; bleeding time does not predict the risk of bleeding and is not indicated. |
| Dose error | |
| Concomitant bleeding disorder | See Bleeding . |